- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Scientist's Selfless Act Could Provide a Lead for Treating TNBC
Dr Koss refused preoperative chemotherapy to avoid damaging her virulent cells, which could later be cultured and could likely provide therapeutic leads.
This year, an estimated 232,000 American women will learn they have breast cancer. On April 28, Kim Koss found out she was one of them.
She took the news as many women do, with shock, fear and sadness. Two weeks later, the news got worse. Hers was a triple-negative cancer, a fast-growing form not fueled by the estrogen, progesterone or HER2/neu gene that are at play in most breast cancers. It meant commonly used drugs and treatments have little benefit for her.
The implications were not lost on Koss, who has a doctorate in biomedical sciences and years of experience with cellular research. Her prognosis was listed as “poor.” “I knew what I was facing,” she says.
It could have immobilized her. Less than a month after her diagnosis, though, her scientist side took charge of what the patient side could not.
Original report: http://cin.ci/1m5Jkn4
Source: Cincinatti
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
